| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.27 | 0.0003 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.15 | 0.0005 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |